Henry Schein Inc. stock outperforms competitors on strong trading day
Henry Schein Inc. closed 6.05% short of its 52-week high of $82.63, which the company achieved on February 27th.
Hosted on MSN4d
3 Reasons HSIC is Risky and 1 Stock to Buy Instead
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...
Fintel on MSN4d
Wells Fargo Initiates Coverage of Henry Schein (HSIC) with Equal-Weight Recommendation
Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of Henry Schein (NasdaqGS:HSIC) with a Equal-Weight ...
Henry Schein initiated with an Equal Weight at Wells Fargo
Wells Fargo initiated coverage of Henry Schein (HSIC) with an Equal Weight rating and $80 price target The stock’s risk/reward is balanced at ...
Henry Schein double upgraded to Buy from Underperform at BofA
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Henry Schein Inc. stock underperforms Friday when compared to competitors
Henry Schein Inc. closed 8.02% below its 52-week high of $82.63, which the company reached on February 27th.
Reuters28d
Exclusive: Activist Ananym plans to launch proxy fight at Henry Schein, sources say
NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...
Business Wire1mon
Henry Schein Completes Acquisition of Acentus
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced it has ...
Yahoo Finance20d
KKR builds stake in Henry Schein, reaches deal to add board seats
(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...